Marseille, France, March 10, 2026 - Vect-Horus, a privately held biotechnology company that designs and develops molecular vectors facilitating the targeted delivery of therapeutic molecules and ...

MARSEILLE, France & HOUSTON--(BUSINESS WIRE)--Vect-Horus and RadioMedix announced today the signing of a Letter of Intent (LOI) to establish an agreement for the co-development of a Vect-Horus ...

MARSEILLE, France, Oct. 30, 2014 (GLOBE NEWSWIRE) -- VECT-HORUS, a biotechnology company that designs and develops peptide vectors facilitating the delivery of drugs or imaging agents, notably in the ...

C-Suite executive with more than 35 years’ experience in international banking Brings important and complementary skills to support company’s development Marseille, France, April 24, 2025 - Vect-Horus ...

Brings extensive experience in investor relations and financial research and analysis Will drive financial strategy to support internal pipeline and partnerships Marseille, France, March 25, 2025 - ...

MARSEILLE, France--(BUSINESS WIRE)--Vect-Horus, a privately held biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging ...

Accomplished research scientist and business professional Brings important skills for both clinical and business development of Vect-Horus Marseille, France, November 14, 2024 - Vect-Horus, a ...

Vect-Horus and RadioMedix are pleased to announce the FDA clearance of exploratory Investigational New Drug (eIND) application to evaluate 68 Ga-RMX-VH for the detection and mapping of Low Density ...

Appointment further strengthens Vect-Horus’ leadership as company continues growth and development Marseille, France, March 10, 2026 - Vect-Horus, a privately held biotechnology company that designs ...

Claudia Fromond, PhD, Vect-Horus Director of Research and Development (R&D). Marseille, France, March 10, 2026 - Vect-Horus, a privately held biotechnology company that designs and develops molecular ...